Immune testing in fertility practice: Truth or deception?

Current Opinion in Obstetrics and Gynecology

Volumn 15, Issue 3, 2003, Pages 225-231

  Kallen, Caleb B ^a   Arici, Aydin ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Antiphospholipid antibody; Antisperm antibody; Antithyroid antibody; Fertility; Immunotherapy; Leukocyte immunization; Natural killer cell; Reproduction

Indexed keywords

ANTINUCLEAR ANTIBODY; PHOSPHOLIPID ANTIBODY; SPERM ANTIBODY; THYROID ANTIBODY;

ANTIBODY DETECTION; CLINICAL PRACTICE; EVIDENCE BASED MEDICINE; FEMALE INFERTILITY; FERTILITY; HUMAN; IMMUNOLOGICAL PROCEDURES; IMMUNOPHENOTYPING; MEDICAL PRACTICE; PREGNANCY; PRIORITY JOURNAL; RECUMBENCY; REVIEW; SPONTANEOUS ABORTION;

ANTIBODIES, ANTIPHOSPHOLIPID; ETHICS, MEDICAL; EVIDENCE-BASED MEDICINE; FEMALE; HUMANS; IMMUNOLOGIC TESTS; INFERTILITY, FEMALE; PREGNANCY; REPRODUCTION; REPRODUCTIVE TECHNIQUES; TREATMENT FAILURE; UNITED STATES;

EID: 0037607013     PISSN: 1040872X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001703-200306000-00003     Document Type: Review

References (87)

1. Coulam CB. Epidemiology of recurrent spontaneous abortion. Am J Reprod Immunol 1991; 26:23-27.
2. Mills JL, Simpson JL, Driscoll SG, et al. Incidence of spontaneous abortion among normal women and insulin-dependent diabetic women whose pregnancies were identified within 21 days of conception. N Engl J Med 1988; 319:1617-1623.
3. Branch DW, Silver R, Pierangeli S, et al. Antiphospholipid antibodies other than lupus anticoagulant and anticardiolipin antibodies in women with recurrent pregnancy loss, fertile controls, and antiphospholipid syndrome. Obstet Gynecol 1997; 89:549-555.
4. Yetman DL, Kutteh WH. Antiphospholipid antibody panels and recurrent pregnancy loss: prevalence of anticardiolipin antibodies compared with other antiphospholipid antibodies. Fertil Steril 1996; 66:540-546.
5. Parke AL, Wilson D, Maier D. The prevalence of antiphospholipid antibodies in women with recurrent spontaneous abortion, women with successful pregnancies, and women who have never been pregnant. Arthritis Rheum 1991; 34:1231-1235.
6. Gleicher N, el-Roeiy A, Confino E, Friberg J. Reproductive failure because of autoantibodies: unexplained infertility and pregnancy wastage. Am J Obstet Gynecol 1989; 160:1376-1380; discussion 1380-1385.
7. Petri M, Golbus M, Anderson R, et al. Antinuclear antibody, lupus anticoagulant, and anticardiolipin antibody in women with idiopathic habitual abortion. A controlled, prospective study of forty-four women. Arthritis Rheum 1987; 30:601-606.
8. Cowchock S, Smith JB, Gocial B. Antibodies to phospholipids and nuclear antigens in patients with repeated abortions. Am J Obstet Gynecol 1986; 155:1002-1010.
9. Rai RS, Clifford K, Cohen H, Regan L. High prospective fetal loss rate in untreated pregnancies of women with recurrent miscarriage and antiphospholipid antibodies. Hum Reprod 1995; 10:3301-3304.
10. Oshiro BT, Silver RM, Scott JR, et al. Antiphospholipid antibodies and fetal death. Obstet Gynecol 1996; 87:489-493.
11. Lockwood CJ, Romero R, Feinberg RF, et al. The prevalence and biologic significance of lupus anticoagulant and anticardiolipin antibodies in a general obstetric population. Am J Obstet Gynecol 1989; 161:369-373.
12. el-Roeiy A, Gleicher N. Definition of normal autoantibody levels in an apparently healthy population. Obstet Gynecol 1988; 72:596-602.
13. Taylor PV, Campbell JM, Scott JS. Presence of autoantibodies in women with unexplained infertility. Am J Obstet Gynecol 1989; 161:377-379.
14. Roussev RG, Kaider BD, Price DE, Coulam CB. Laboratory evaluation of women experiencing reproductive failure. Am J Reprod Immunol 1996; 35:415-420.
15. el-Roeiy A, Gleicher N, Friberg J, et al. Correlation between peripheral blood and follicular fluid autoantibodies and impact on in vitro fertilization. Obstet Gynecol 1987; 70:163-170.
16. Birdsall MA, Lockwood GM, Ledger WL, et al. Antiphospholipid antibodies in women having in-vitro fertilization. Hum Reprod 1996; 11:1185-1189.
17. Kutteh WH, Yetman DL, Chantilis SJ, Crain J. Effect of antiphospholipid antibodies in women undergoing in-vitro fertilization: role of heparin and aspirin. Hum Reprod 1997; 12:1171-1175.
18. Eldar-Geva T, Wood C, Lolatgis N, et al. Cumulative pregnancy and live birth rates in women with antiphospholipid antibodies undergoing assisted reproduction. Hum Reprod 1999; 14:1461-1466.
19. Gleicher N, Liu HC, Dudkiewicz A, et al. Autoantibody profiles and immunoglobulin levels as predictors of in vitro fertilization success. Am J Obstet Gynecol 1994; 170:1145-1149.
20. Hornstein MD. Antiphospholipid antibodies in patients undergoing IVF: the data do not support testing. Fertil Steril 2000; 74:635-636.
21. A rational basis for antiphospholipid antibody testing and selective immunotherapy in assisted reproduction: a rebuttal to the American Society for Reproductive Medicine practice opinion. American Society for Reproductive Immunology Antiphospholipid Antibody Committee. Fertil Steril 2000; 74:631-634.
22. Hill JA, Scott RT. Immunologic tests and IVF: 'please, enough already'. Fertil Steril 2000; 74:439-442.
23. Sher G, Feinman M, Zouves C, et al. High fecundity rates following in-vitro fertilization and embryo transfer in antiphospholipid antibody seropositive women treated with heparin and aspirin. Hum Reprod 1994; 9:2278-2283.
24. Birkenfeld A, Mukaida T, Minichiello L, et al. Incidence of autoimmune antibodies in failed embryo transfer cycles. Am J Reprod Immunol 1994; 31:65-68.
25. Geva E, Yaron Y, Lessing JB, et al. Circulating autoimmune antibodies may be responsible for implantation failure in in vitro fertilization. Fertil Steril 1994; 62:802-806.
26. Balasch J, Creus M, Fabregues F, et al. Antiphospholipid antibodies and human reproductive failure. Hum Reprod 1996; 11:2310-2315.
27. Denis AL, Guido M, Adler RD, et al. Antiphospholipid antibodies and pregnancy rates and outcome in in vitro fertilization patients. Fertil Steril 1997; 67:1084-1090.
28. Kowalik A, Vichnin M, Liu HC, et al. Midfollicular anticardiolipin and antiphosphatidylserine antibody titers do not correlate with in vitro fertilization outcome. Fertil Steril 1997; 68:298-304.
29. Chilcott IT, Margara R, Cohen H, et al. Pregnancy outcome is not affected by antiphospholipid antibody status in women referred for in vitro fertilization. Fertil Steril 2000; 73:526-530.
30. Hornstein MD, Davis OK, Massey JB, et al. Antiphospholipid antibodies and in vitro fertilization success: a meta-analysis. Fertil Steril 2000; 73:330-333.
31. American Society for Reproductive Medicine. Practice Committee Report. Antiphospholipid antibodies do not affect IVF success. American Society for Reproductive Medicine; 1999.
32. Cowchock FS, Reece EA, Balaban D, et al. Repeated fetal losses associated with antiphospholipid antibodies: a collaborative randomized trial comparing prednisone with low-dose heparin treatment. Am J Obstet Gynecol 1992; 166:1316-1323.
33. Kutteh WH. Antiphospholipid antibody-associated recurrent pregnancy loss: treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone. Am J Obstet Gynecol 1996; 174:1584-1589.
34. Kutteh WH, Ermel LD. A clinical trial for the treatment of antiphospholipid antibody-associated recurrent pregnancy loss with lower dose heparin and aspirin. Am J Reprod Immunol 1996; 35:402-407.
35. Stern C, Chamley L, Hale L, et al. Antibodies to beta2 glycoprotein I are associated with in vitro fertilization implantation failure as well as recurrent miscarriage: results of a prevalence study. Fertil Steril 1998; 70:936-944.
36. Batasch J, Reverter JC, Creus M, et al. Human reproductive failure is not a clinical feature associated with beta(2) glycoprotein-I antibodies in anticardiolipin and lupus anticoagulant seronegative patients (the antiphospholipid/cofactor syndrome). Hum Reprod 1999; 14:1956-1959.
37. Stagnaro-Green A, Roman SH, Cobin RH, et al. Detection of at-risk pregnancy by means of highly sensitive assays for thyroid autoantibodies. JAMA 1990; 264:1422-1425.
38. Kutteh WH, Yetman DL, Carr AC, et al. Increased prevalence of antithyroid antibodies identified in women with recurrent pregnancy loss but not in women undergoing assisted reproduction. Fertil Steril 1999; 71:843-848.
39. Bussen SS, Steck T. Thyroid antibodies and their relation to antithrombin antibodies, anticardiolipin antibodies and lupus anticoagulant in women with recurrent spontaneous abortions (antithyroid, anticardiolipin and antithrombin autoantibodies and lupus anticoagulant in habitual aborters). Eur J Obstet Gynecol Reprod Biol 1997; 74:139-143.
40. Dendrinos S, Papasteriades C, Tarassi K, et al. Thyroid autoimmunity in patients with recurrent spontaneous miscarriages. Gynecol Endocrinol 2000; 14:270-274.
41. Esplin MS, Branch DW, Silver R, Stagnaro-Green A. Thyroid autoantibodies are not associated with recurrent pregnancy loss. Am J Obstet Gynecol 1998; 179:1583-1586.
42. Rushworth FH, Backos M, Rai R, et al. Prospective pregnancy outcome in untreated recurrent miscarriers with thyroid autoantibodies. Hum Reprod 2000; 15:1637-1639.
43. Hollowell JG, Staehling NW, Flanders WD, et al. Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab 2002; 87:489-499. Large-scale and current prevalence data are provided, with categorization by antibody type, age, sex, and ethnicity.
44. Sher G, Maassarani G, Zouves C, et al. The use of combined heparin/aspirin and immunoglobulin G therapy in the treatment of in vitro fertilization patients with antithyroid antibodies. Am J Reprod Immunol 1998; 39:223-225.
45. Geva E, Lessing JB, Lerner-Geva L, et al. The presence of antithyroid antibodies in euthyroid patients with unexplained infertility and tubal obstruction. Am J Reprod Immunol 1997; 37:184-186.
46. Kutteh WH, Schootcraft WB, Scott Jr RT. Antithyroid antibodies do not affect pregnancy outcome in women undergoing assisted reproduction. Hum Reprod 1999; 14:2886-2890.
47. Wilson C, Elstein M, Eade OE, et al. Smooth-muscle antibodies in infertility. Lancet 1975; 2:1236-1239.
48. Geva E, Amit A, Lerner-Geva L, et al. Autoimmune disorders: another possible cause for in-vitro fertilization and embryo transfer failure. Hum Reprod 1995; 10:2560-2563.
49. Cubillos J, Lucena A, Lucena C, et al. Incidence of autoantibodies in the infertile population. Early Pregnancy 1997; 3:119-124.
50. Geva E, Amit A, Lerner-Geva L, et al. Prednisone and aspirin improve pregnancy rate in patients with reproductive failure and autoimmune antibodies: a prospective study. Am J Reprod Immunol 2000; 43:36-40.
51. Kim CH, Cho YK, Mok JE. The efficacy of immunotherapy in patients who underwent superovulation with intrauterine insemination. Fertil Steril 1996; 65:133-138.
52. Kremer J, Jager S. The sperm - cervical mucus contact test: a preliminary report. Fertil Steril 1976; 27:335-340.
53. Jager S, Kremer J, Kuiken J, van Slochteren-Draaisma T. Immunoglobulin class of antispermatozoal antibodies from infertile men and inhibition of in vitro sperm penetration into cervical mucus. Int J Androl 1980; 3:1-14.
54. Bronson RA, Cooper GW, Rosenfeld DL. Sperm-specific isoantibodies and autoantibodies inhibit the binding of human sperm to the human zona pellucida. Fertil Steril 1982; 38:724-729.
55. Zouari R, De Almeida M. Effect of sperm-associated antibodies on human sperm ability to bind to zona pellucida and to penetrate zona-free hamster oocytes. J Reprod Immunol 1993; 24:175-186.
56. Haas Jr GO, Sokoloski JE, Wolf DP. The interfering effect of human IgG antisperm antibodies on human sperm penetration of zona-free hamster eggs. Am J Reprod Immunol 1980; 1:40-43.
57. Clarke ON, Lopata A, McBain JC, et al. Effect of sperm antibodies in males on human in vitro fertilization (IVF). Am J Reprod Immunol Microbiol 1985; 8:62-66.
58. Rajah SV, Parslow JM, Howell RJ, Hendry WF. The effects on in-vitro fertilization of autoantibodies to spermatozoa in subfertile men. Hum Reprod 1993; 8:1079-1082.
59. Naz RK. Effects of antisperm antibodies on early cleavage of fertilized ova. Biol Reprod 1992; 46:130-139.
60. Kutteh WH. Antisperm antibodies. Do antisperm antibodies bound to spermatozoa alter normal reproductive function? Hum Reprod 1999; 14:2426-2429.
61. World Health Organization. Laboratory manual for the examination of human semen and sperm - cervical mucus interaction. New York: Cambridge University Press; 1992. pp. 3-27.
62. Culligan PJ, Crane MM, Boone WR, et al. Validity and cost-effectiveness of antisperm antibody testing before in vitro fertilization. Fertil Steril 1998; 69:894-898.
63. Vazquez-Levin MH, Notrica JA, Polak de Fried E. Male immunologic infertility: sperm performance on in vitro fertilization. Fertil Steril 1997; 68:675-681.
64. Sukcharoen N, Keith J. The effect of the antisperm auto-antibody-bound sperm on in vitro fertilization outcome. Andrologia 1995; 27:281-289.
65. Ford WC, Williams KM, McLaughtin EA, et al. The indirect immunobead test for seminal antisperm antibodies and fertilization rates at in-vitro fertilization. Hum Reprod 1996; 11:1416-1422.
66. Haas Jr GO, D'Cruz OJ, Denum BM. Effect of repeated washing on sperm-bound immunoglobulin G. J Androl 1988; 9:190-196.
67. Byrd W, Kutteh WH, Carr BR. Treatment of antibody-associated sperm with media containing high serum content: a prospective trial of fertility involving men with high antisperm antibodies following intrauterine insemination. Am J Reprod Immunol 1994; 31:84-90.
68. Kutteh WH, Kilian M, Ermel LD, et al. Antisperm antibodies (ASAs) in infertile males: subclass distribution of IgA antibodies and the effect of an IgA1 protease on sperm-bound antibodies. Am J Reprod Immunol 1994; 31:77-83.
69. Katsoff D, Check JH, Bollendorf A, Benfer K. Chymotrypsin-galactose treatment of sperm with antisperm antibodies results in improved pregnancy rates following in vitro fertilization. Am J Reprod Immunol 1995; 33:149-154.
70. Shin D, Palermo GD, Goldstein M, et al. Indications for corticosteroids prior to epididymal sperm retrieval. Int J Fertil Womens Med 1998; 43:165-170.
71. Sharma KK, Barratt CL, Pearson MJ, Cooke ID. Oral steroid therapy for subfertile males with antisperm antibodies in the semen: prediction of the responders. Hum Reprod 1995; 10:103-109.
72. Haas Jr GG, Manganiello P. A double-blind, placebo-controlled study of the use of methylprednisolone in infertile men with sperm-associated immunoglobulins. Fertil Steril 1987; 47:295-301.
73. Dondero F, Isidori A, Lenzi A, et al. Treatment and follow-up of patients with infertility due to spermagglutinins. Fertil Steril 1979; 31:48-51.
74. Janssen HJ, Bastiaans BA, Goverde HJ, et al. Antisperm antibodies and in vitro fertilization. J Assist Reprod Genet 1992; 9:345-349.
75. Lahteenmaki A, Rasanen M, Hovatta O. Low-dose prednisolone does not improve the outcome of in-vitro fertilization in male immunological infertility. Hum Reprod 1995; 10:3124-3129.
76. Mercan R, Oehninger S, Muasher SJ, et al. Impact of fertilization history and semen parameters on ICSI outcome. J Assist Reprod Genet 1998; 15:39-45.
77. Clarke GN, Bourne H, Baker HW. Intracytoplasmic sperm injection for treating infertility associated with sperm autoimmunity. Fertil Steril 1997; 68:112-117.
78. Lahteenmaki A, Reima I, Hovatta O. Treatment of severe male immunological infertility by intracytoplasmic sperm injection. Hum Reprod 1995; 10:2824-2828.
79. Krapez JA, Hayden CJ, Rutherford AJ, Balen AH. Survey of the diagnosis and management of antisperm antibodies. Hum Reprod 1998; 13:3363-3367.
80. Aoki K, Kajiura S, Matsumoto Y, et al. Preconceptional natural-killer-cell activity as a predictor of miscarriage. Lancet 1995; 345:1340-1342.
81. Kwak JY, Beaman KD, Gilman-Sachs A, et al. Up-regulated expression of CD56+, CD56+/CD16+, and CD19+ cells in peripheral blood lymphocytes in pregnant women with recurrent pregnancy losses. Am J Reprod Immunol 1995; 34:93-99.
82. Mowbray JF, Gibbings C, Liddell H, et al. Controlled trial of treatment of recurrent spontaneous abortion by immunisation with paternal cells. Lancet 1985; 1:941-943.
83. Gatenby PA, Cameron K, Simes R J, et al. Treatment of recurrent spontaneous abortion by immunization with paternal lymphocytes: results of a controlled trial. Am J Reprod Immunol 1993; 29:88-94.
84. Worldwide collaborative observational study and meta-analysis on allogenic leukocyte immunotherapy for recurrent spontaneous abortion. Recurrent Miscarriage Immunotherapy Trialists Group. Am J Reprod Immunol 1994; 32:55-72.
85. Cauchi MN, Lim D, Young DE, et al. Treatment of recurrent aborters by immunization with paternal cells - controlled trial. Am J Reprod Immunol 1991; 25:16-17.
86. Ho HN, Gill III TJ, Hsieh HJ, et al. Immunotherapy for recurrent spontaneous abortions in a chinese population. Am J Reprod Immunol 1991; 25:10-15.
87. Ober C, Karrison T, Odem RR, et al. Mononuclear-cell immunisation in prevention of recurrent miscarriages: a randomised trial. Lancet 1999; 354:365-369.